Key points
- NAD+ precursors like NR and NMN are central to fat and energy metabolism, which is why "NAD+ for weight loss" sounds plausible — but plausible isn't proven.
- The human trials that measured body weight and composition have, on the whole, not shown meaningful weight loss from NAD+ supplements.
- Some studies hint at modest metabolic shifts (such as small reductions in liver fat), but these fell short of statistical significance or didn't translate into the scale moving.
Short answer: no — despite the metabolism marketing, human trials have not shown that NAD+ supplements cause weight loss. Nicotinamide riboside (NR) and NMN sit at the heart of how cells burn fuel, so the hypothesis is reasonable. But when researchers actually put obese and overweight people on these supplements and measured their weight and body composition, the supplements proved safe and well tolerated while consistently failing to produce meaningful weight loss. The fair reading: NAD+ is not a weight-loss tool, and any "before and after" framing outruns the evidence.
Why would NAD+ affect weight at all?
NAD+ powers the mitochondrial reactions that turn fat and glucose into usable energy, and it activates sirtuins involved in metabolic regulation. In rodent studies, boosting NAD+ improved insulin sensitivity and reduced fat accumulation, sometimes dramatically. That preclinical signal is exactly what drove the idea that NAD+ precursors could help humans lose weight or improve metabolic health. The catch — a recurring theme in this field — is that mice are not 60-year-old humans, and the effects that look striking in animals have repeatedly shrunk or vanished in people. For the parallel story on energy, see whether NAD+ actually makes you feel less tired.
What human studies actually show
The first major obesity trial: safe, but no weight loss. In a 12-week randomized, placebo-controlled trial, 40 sedentary obese men (BMI >30, ages 40–70) took 1,000 mg of NR twice daily. The supplement was safe and well tolerated — but it did not produce weight loss, and the primary endpoint of improved insulin sensitivity was not met (PMID 29992272; DOI 10.1093/ajcn/nqy132). A commentary noted a non-significant 2% reduction in liver fat in the NR group versus 0.2% in placebo (P = 0.13) — a hint, not a result.
A crossover trial in overweight/obese adults: no insulin or mitochondrial benefit. A randomized, double-blind, placebo-controlled crossover study gave 13 healthy overweight or obese men and women 1,000 mg/day of NR for 6 weeks. Markers of NAD+ synthesis rose in muscle, confirming the supplement was active — yet NR did not improve insulin sensitivity or muscle mitochondrial function, and the body-composition changes were limited (DOI 10.1093/ajcn/nqaa072). Once again, NAD+ went up; the metabolic payoff did not.
The systematic review picture. A systematic review and meta-regression of NAD+ precursor supplementation (nicotinic acid and nicotinamide) on weight and related hormones found the overall effect on weight loss to be limited and inconsistent across randomized trials (DOI 10.3389/fnut.2023.1208734). And a separate meta-analysis of oral NMN on glucose and lipid metabolism, pooling 513 participants across 12 trials, similarly found NMN's metabolic effects modest rather than transformative.
The honest counterweight — and it's the whole story here. Unlike some topics where there's a clear positive trial balanced by a null one, the weight-loss literature is consistently underwhelming. The strongest single message is that NAD+ precursors are safe but do not move the scale in humans. The most generous reading is that subtle metabolic shifts (a touch less liver fat, altered fat handling) may occur, possibly more so when combined with exercise — which is precisely what some researchers have called for testing next.
Study snapshot — the 12-week NR obesity trial
Design: 12-week randomized, double-blind, placebo-controlled, parallel-group. Population: 40 obese, insulin-resistant men. Dose: NR 1,000 mg twice daily. Result: safe and well tolerated, but no weight loss and no significant improvement in insulin sensitivity; only a non-significant trend toward lower liver fat.
Illustrative, not plotted from pooled data: the striking metabolic effects in rodents have not carried over to body-weight outcomes in human NAD+ trials.
What NAD+ supplements won't do for weight
They won't burn fat on their own, won't substitute for a calorie deficit, and won't deliver the "before and after" transformations sometimes implied online. Taking NAD+ and expecting the scale to drop is not supported by the trials. Weight that won't budge, or unexplained weight change, can also signal thyroid problems, medication effects, sleep disorders, or other medical issues. If your weight or metabolism has changed in a way you can't explain, see a clinician — that's a medical question, not a supplement one. Sustainable weight change still comes down to nutrition, activity, sleep, and, where appropriate, clinically supervised options.
Dosing and timeline — for those using NAD+ for other reasons
If you're taking an NAD+ precursor for general cellular-health reasons rather than weight, the doses studied for metabolism sat around 1,000–2,000 mg/day of NR for 6–12 weeks. Even at those doses and durations, weight didn't meaningfully change — so there's no "weight-loss protocol" to offer, because the outcome wasn't there. If weight loss is your actual goal, your time is better spent on an evidence-based approach to diet and movement. For the broader benefit question, our review of what the human evidence supports for NAD+ lays out where the data is stronger and weaker.
Frequently asked questions
Does NAD+ help you lose weight?
The human trials say no — NAD+ precursors were safe but did not produce meaningful weight loss, even in obese participants at high doses over several weeks.
What about NR or NMN specifically for fat loss?
Both have been tested. NR trials in obese adults showed no weight loss; NMN meta-analyses show only modest metabolic effects. Neither is a fat-loss agent on current evidence.
But I've seen NAD+ weight-loss before-and-afters?
Anecdotes and marketing aren't trials. The controlled studies that actually measured weight didn't find the effect. Any visible change in a testimonial is more plausibly explained by diet, exercise, or other factors.
Could NAD+ help metabolism alongside exercise?
It's an open question. Some researchers have specifically called for testing NAD+ precursors combined with exercise, because the trials so far didn't include structured activity. Until that's done, it's a hypothesis.
Is it safe to take NAD+ while trying to lose weight?
The trials found NAD+ precursors safe and well tolerated. Just don't expect them to drive the weight loss — and talk to a clinician if you have a medical condition or take medications.
From Nuvirox
Why we formulated NAD+ Restore
We're upfront that NAD+ Restore isn't a weight-loss product. It's built around 500 mg of Nicotinamide Riboside Chloride (NR) per 2-capsule serving — one of the two most-researched NAD+ precursors, within the dose range used in published human trials — for cellular-health support. It includes 150 mg trans-resveratrol (Japanese Knotweed) and 50 mg quercetin (Sophora japonica), polyphenols studied alongside NAD+ pathways for cellular health support, plus 10 mg galactomannans from fenugreek to support absorption. Backed by a 60-day money-back guarantee, long enough to actually evaluate it the way the research says you should.
Learn more about NAD+ Restore →The bottom line
The metabolism story behind NAD+ is real at the level of biochemistry — these precursors genuinely sit at the center of how cells burn fuel. But biochemistry isn't the same as the scale moving, and on that question the human trials are clear and consistent: NAD+ precursors are safe and well tolerated, and they do not produce meaningful weight loss, even in obese participants at high doses. A few hints of subtle metabolic shifts exist, and combining NAD+ with exercise hasn't been properly tested — but as of today, "NAD+ for weight loss" is a claim the evidence doesn't back. If losing weight is the goal, the proven levers remain nutrition, activity, and sleep, with medical guidance where it's warranted.
References
- Dollerup OL, et al. A randomized placebo-controlled clinical trial of nicotinamide riboside in obese men: safety, insulin-sensitivity, and lipid-mobilizing effects. Am J Clin Nutr. 2018;108(2):343–353. PMID: 29992272. DOI: 10.1093/ajcn/nqy132.
- Remie CME, et al. Nicotinamide riboside supplementation alters body composition and skeletal muscle acetylcarnitine concentrations in healthy obese humans. Am J Clin Nutr. 2020;112(2):413–426. DOI: 10.1093/ajcn/nqaa072.
- The effects of NAD+ precursor (nicotinic acid and nicotinamide) supplementation on weight loss and related hormones: a systematic review and meta-regression analysis of randomized controlled trials. Front Nutr. 2023. DOI: 10.3389/fnut.2023.1208734.
*These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease. This article is for informational purposes only and is not a substitute for professional medical advice.